We are inviting selected investors to an exclusive closed-door Financial Deep Dive on July 8 on Glucowear, the next-generation pain-free, real-time continuous glucose monitoring technology developed by Afon Technology Ltd.

The session will provide a detailed overview of the company’s financial position, commercial strategy, growth trajectory, and fundraising plans. The senior leadership team will walk through key financial metrics, clinical and regulatory progress, manufacturing strategy, and the roadmap toward commercialization.

Glucowear is currently raising a £7.5M Series A round to support final clinical trials, regulatory approvals, manufacturing scale-up, and team expansion.

This is a 2-hour live video session at 8:00 AM EST, designed for in-depth discussion with the founding and leadership team.